Item 2.02 Results of Operations and Financial Condition
On
This information, including the information contained in the press release furnished as Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any of the Company's filings, whether made before or after the date hereof, regardless of any general incorporation language in any such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No. Description 99.1 Press Release ofZiopharm Oncology, Inc. datedAugust 6, 2020 10.4 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
--------------------------------------------------------------------------------
© Edgar Online, source